We prepare a quasi-2D gas of argon atoms confined in a planar matter waveguide in close vicinity (,1 mm) of a reflecting surface. The (anti-)nodes of a far off resonant standing light wave in front of the surface provide a confining potential for the atomic motion normal to the surface. A cloud of cold atoms that approaches the surface is compressed by deceleration in an evanescent field and loaded predominantly into one single potential well close to the surface by optical pumping. The spatial density achieved is more than 100 times higher than the density of the approaching atoms.[S0031-9007(98)

A new endoscope with optimised divertor view has been developed in order to survey and monitor the emission of specific impurities such as tungsten and the remaining carbon as well as beryllium in the tungsten divertor of JET after the implementation of the ITER-like wall in 2011. The endoscope is a prototype for testing an ITER relevant design concept based on reflective optics only. It may be subject to high neutron fluxes as expected in ITER. The operating wavelength range, from 390 nm to 2500 nm, allows the measurements of the emission of all expected impurities (W I, Be II, C I, C II, C III) with high optical transmittance (≥ 30% in the designed wavelength range) as well as high spatial resolution that is ≤ 2 mm at the object plane and ≤ 3 mm for the full depth of field (± 0.7 m). The new optical design includes options for in situ calibration of the endoscope transmittance during the experimental campaign, which allows the continuous tracing of possible transmittance degradation with time due to impurity deposition and erosion by fast neutral particles. In parallel to the new optical design, a new type of possibly ITER relevant shutter system based on pneumatic techniques has been developed and integrated into the endoscope head. The endoscope is equipped with four digital CCD cameras, each combined with two filter wheels for narrow band interference and neutral density filters. Additionally, two protection cameras in the λ > 0.95 μm range have been integrated in the optical design for the real time wall protection during the plasma operation of JET.

No abstract

MICADO will equip the E-ELT with a first light capability for diffraction limited imaging at near-infrared wavelengths. The instrument's observing modes focus on various flavours of imaging, including astrometric, high contrast, and time resolved. There is also a single object spectroscopic mode optimised for wavelength coverage at moderately high resolution. This contribution provides an overview of the key functionality of the instrument, outlining the scientific rationale for its observing modes. The interface between MICADO and the adaptive optics system MAORY that feeds it is summarised. The design of the instrument is discussed, focussing on the optics and mechanisms inside the cryostat, together with a brief overview of the other key sub-systems.

The objective of the study was to investigate the first-night treatment success of a nasopharyngeal stent compared to standard nCPAP-titration. This is a case series and a single-center study. Eight participants (n = 8) were selected with untreated obstructive sleep apnea with a prestudy AHI ≥ 10. A newly developed nasopharyngeal stent was tested individually versus standard nCPAP-titration. Cardiorespiratory polysomnography was performed on two consecutive nights (random order: stent, nCPAP). The AHI, the number of obstructive apneas and hypopneas, the mean oxygen saturation, and the minimum oxygen saturation were compared before and after using the nasopharyngeal stent or standard nCPAP. The AHI value before treatment (AHIpre) was 31.1 ± 12.0 (mean ± standard deviation). After inserting the AlaxoStent, the mean AHIstent was 19 ± 12.0 compared to mean AHInCPAP 8.2 ± 11.9 with standard nCPAP-titration. Both nasopharyngeal stenting and nCPAP-titration could reduce the mean number of obstructive apneas by >94 %. Compared to responder rates of classic surgical interventions like uvulopalatopharyngoplasty or multi-level surgery, the nasopharyngeal stent seems to give a comparable responder rate of 50 %. There were no complications associated with the use of the stent and it was well tolerated by all subjects. Nasopharyngeal stenting widens the range of non-invasive mechanical treatment and seems to be an effective mechanical therapeutic alternative to surgery in nCPAP non-compliant patients with OSA. Careful selection of the patient population is a prerequisite of treatment and therefore it should be reserved for individual cases only.